NICE is unable to make a recommendation on ciltacabtagene autoleucel (Carvykti) for treating relapsed or refractory multiple myeloma in adults. This is because Janssen withdrew its evidence submission for the appraisal. We will review this decision if the company decides to make a submission....
NICE is unable to make a recommendation on teclistamab (Tecvayli) for treating relapsed or refractory multiple myeloma after 3 or more therapies in adults. This is because Agios did not provide an evidence submission. We will review this decision if the company decides to make a submission....
El Mieloma Múltiple es un tipo de neoplasia hematológica maligna incurable en la actualidad, que se caracteriza
por la afección y multiplicación sin control de células plasmáticas en la médula ósea con su consecuente secreción
de una proteína monoclonal y síntomas como anemia, hipercalcemia, f...
This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications....
"BACKGROUND AND OBJECTIVE:
Poor mobilization of peripheral blood stem cells (CD34(+) cells) from bone marrow is a frequent reason for not reaching the autologous stem cell trasplantation (SCT) procedure in patients diagnosed with lymphoma or myeloma. Plerixafor, a reversible inhibitor of the binding of s...
This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma
and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people
with myeloma by promoting the most effective tests and treatments for myeloma and its
complications....
This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications. This guideline...
Barosi, Giovanni;
Merlini, Giampaolo;
Atto, Billio;
Boccadoro, Mario;
Corradini, Paolo;
Marchetti, Monia;
Massaia, Massimo;
Tosi, Patrizia;
Palumbo, Antonio;
Cavo, Michele;
Tura, Sante.
In this project, we produced drug-specific recommendations targeting the use of new agents for multiple myeloma (MM). We used the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) system which separates the judgments on quality of evidence from the judgment about strength of recom...
Protocolos de Quimioterapia Combinada Antineoplásica,
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación,
Ácidos Borónicos/uso terapéutico,
Bortezomib/uso terapéutico,
Hematología/legislación & jurisprudencia,
Hematología/métodos,
Lenalidomida/uso terapéutico,
Mieloma Múltiple/patología,
Clasificación del Tumor,
Pirazinas/administración & dosificación,
Sociedades Médicas/legislación & jurisprudencia,
Talidomida/uso terapéutico
